French pharmaceutical company sends team to Israel

October 23, 2006 13:52


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


French pharmaceutical company Sanofi-Aventis said Monday that it was sending experts to Israel to study the deaths of four people who had recently received flu shots. Sanofi-Aventis said its team in Israel would try to find out more about the people who died. The four people, who were elderly and suffered from chronic illnesses, had received flu shots up to six days before their deaths, company spokesman Alain Bernal said. "We are taking this seriously, we are studying it seriously, but we have total confidence in the quality of our product," Bernal said. "This is a vaccine that saves thousands of lives every year."

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

OVERVIEW OF the Human Rights Council at the UNHRC
September 21, 2018
UNHRC appoints new Gaza probe chairman